The briefing
Sun Pharma received approval from SAHPRA to market a generic semaglutide injection for type 2 diabetes in South Africa. The authorization expands competition in the GLP-1 diabetes treatment market.
Original headline
Sun Pharma gets nod from South African regulator for generic semaglutide injection